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During embryonic development, multipotent cardio-
vascular progenitor cells are specified from early
mesoderm. Using mouse ESCs in which gene ex-
pression can be temporally regulated, we have found
that transient expression of Mesp1 dramatically ac-
celerates and enhances multipotent cardiovascular
progenitor specification through an intrinsic and
cell autonomous mechanism. Genome-wide tran-
scriptional analysis indicates that Mesp1 rapidly ac-
tivates and represses a discrete set of genes, and
chromatin immunoprecipitation shows that Mesp1
directly binds to regulatory DNA sequences located
in the promoter of many key genes in the core cardiac
transcriptional machinery, resulting in their rapid up-
regulation. Mesp1 also directly represses the expres-
sion of key genes regulating other early mesoderm
and endoderm cell fates. Our results demonstrate
that Mesp1 acts as a key regulatory switch during
cardiovascular specification, residing at the top of
the hierarchy of the gene network responsible for
cardiovascular cell-fate determination.
INTRODUCTION
The heart is the first functional organ that is formed during
embryonic development. The ancestor of the primitive heart is
estimated to have arisen about 500 million years ago, since the
core transcriptional machinery required for cardiac differentia-
tion has been extremely conserved during evolution (Davidson
and Erwin, 2006; Olson, 2006; Satou and Satoh, 2006). Cardiac
progenitors are specified during the early stages of gastrulation
as soon as the epiblast cells are incorporated within the cranial
portion of the primitive streak. Around embryonic day 6 (E6.0)
in mice, the prospective cardiogenic mesoderm migrates away
from the primitive streak bilaterally and cranially to form the an-
terior and lateral plate mesoderm (E6.5), where the cardiac cres-
cent, corresponding to the primary heart field, appears at around
E7.0 (Abu-Issa and Kirby, 2007; Buckingham et al., 2005; Garry
and Olson, 2006). The cells of the cardiac crescent migrate me-
dially and form a linear single heart tube, which will give rise to
the cells of the left ventricle and atria. Complex looping and rota-
tion of the heart tube, as well as the addition of cells coming fromthe secondary heart field, giving rise to the right ventricle and the
outflow track, generate a four-chambered heart (Buckingham
et al., 2005; Laugwitz et al., 2008).
Various lines of evidence have suggested that different car-
diac cell types, including cardiomyocytes, endothelial cells,
smooth muscle cells, as well as conduction cells, which com-
pose the mature heart tissue, arise from the differentiation of
multipotent cardiovascular progenitors (MCPs) generated soon
after gastrulation (Garry and Olson, 2006; Moretti et al., 2006;
Wu et al., 2006). Recent studies also provide compelling evi-
dence that different sources of MCPs, which are specified during
embryonic development, are also generated during pluripotent
embryonic stem cell (ESC) differentiation (Murry and Keller,
2008). These MCPs can be isolated on the basis of Brachyury
and Flk1 expression for early cardiac progenitors (Kattman
et al., 2006; Kouskoff et al., 2005; Yang et al., 2008) and using
Nkx2-5 and Islet1 reporter genes for isolating cardiovascular
progenitors of the primary (Nkx2-5) and the secondary heart
fields (Nkx2-5 and Islet1) (Moretti et al., 2006; Wu et al., 2006).
ESC differentiation represents a very attractive model to dissect
the molecular mechanisms implicated in cardiovascular cell-fate
specification but also may represent an ideal source of cardio-
vascular cells for cellular therapy in humans (Martin-Puig et al.,
2008).
Although the gene regulatory network of transcription factors
involved in cardiac determination, proliferation, patterning, and
differentiation is relatively well known, the early molecular mech-
anism that induces the specification of multipotent cardiovascu-
lar cell fate from undifferentiated mesoderm remains largely un-
known (Abu-Issa and Kirby, 2007; Olson, 2006). It is still unclear
what are the intrinsic or extrinsic factors that induce cardiovas-
cular progenitor specification and coordinate the expression of
cardiac transcription factors at the right time and at the right
place.
Expression of Mesp1, a transcription factor of the b-HLH
family, is one of the earliest signs of cardiovascular development
in vertebrates (Saga et al., 2000). During gastrulation in mice,
Mesp1 is strongly expressed at the onset of gastrulation (E6.5)
along the primitive streak and in the prospective cardiac meso-
derm and is then rapidly downregulated after E7.5 (Saga et al.,
1996). Lineage-tracing experiments using mice in which the
Cre recombinase has been knocked in into the Mesp1 locus
demonstrated that most cardiac cells and some vascular cells
arise from cells that expressedMesp1 at one point of their devel-
opment (Saga et al., 1999).Mesp1 null mice present a severe de-
fect in heart morphogenesis that has been attributed to a delay inCell Stem Cell 3, 69–84, July 2008 ª2008 Elsevier Inc. 69
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Mesp1/2 null mice exhibit a major defect in gastrulation resulting
in the absence of mesoderm formation (Kitajima et al., 2000).
This dramatic and early gastrulation defect has precluded
molecular characterization of the specific role of Mesp1/2 during
cardiac specification, and left open the question about the
precise mechanism by which Mesp1 acts during cardiac devel-
opment. Does Mesp1 only promote the migration of cardiac
progenitors toward the lateral plate mesoderm, or does Mesp1
instruct the primitive mesoderm to become MCPs?
To dissect the cellular and the molecular mechanism by which
Mesp1 acts during cardiac specification, we took advantage of
the natural differentiation of ESCs into MCPs and the ease of
their genetic manipulation (Murry and Keller, 2008). We showed
that, during ESC differentiation, Mesp1 is expressed very tran-
siently, reminiscent of its expression during embryonic develop-
ment. By transiently overexpressing Mesp1 during ESC differen-
tiation, we drastically accelerated and promoted specifically
cardiovascular cell fate through a cell autonomous mechanism.
Using genome wide transcriptional analysis after Mesp1 induc-
tion, we uncovered a discrete set of genes that are rapidly regu-
lated upon Mesp1 induction. We showed that Mesp1 both
directly activated many key genes belonging to the core cardiac
transcriptional machinery and directly repressed genes promot-
ing early mesoderm and endoderm cell-fate specification.
Mesp1 first transiently stimulated its own endogenous expres-
sion through a direct positive autoregulatory loop and then
inhibited its own expression, therefore, acting as a molecular
switch during cardiac specification. Altogether, our results pro-
vide compelling evidence that Mesp1 acts as a cardiovascular
master regulator during specification of MCPs during ESC differ-
entiation.
RESULTS
Transient Expression of Mesp1 Dramatically
Accelerates and Increases Cardiac Differentiation
from ESCs
We first examined by RT-PCR the temporal expression of key
transcription factors implicated in the transition from pluripotent
ESCs to cardiac terminal differentiation (Figure 1A). As previ-
ously shown (Kattman et al., 2006; Kouskoff et al., 2005; Liu
et al., 2007), when pluripotent ESCs are induced to differentiate,
the temporal appearance of the key transcriptional factors impli-
cated in mesoderm and cardiac commitment is very similar to
the temporal expression of these genes during embryonic devel-opment (Murry and Keller, 2008). Genes regulating the specifica-
tion of the primitive streak, such as Brachyury, are strongly and
rapidly upregulated. Mesp1 began to be expressed soon after,
peaked at day 4, and then was rapidly downregulated. Key car-
diac transcription factors began to be expressed at days 3 to 4,
peaking around day 6. Cardiac structural genes, such as tropo-
ninT, began to be expressed at day 5 and peaked at day 8, and
their expression was maintained thereafter, in good accordance
with the contractile phenotype of the cells observed upon micro-
scopic inspection (Figure 1B).
To study the role of Mesp1 during cardiac cell-fate specifica-
tion, we generated a recombinant ESC line in which the expres-
sion of an epitope-tagged version of Mesp1 followed by an IRES-
GFP can be temporally and specifically induced upon doxyclin
(Dox) addition (Figure S1A available online) (Kyba et al., 2002).
To determine whether Mesp1 directly promotes cardiac specifi-
cation, we induced the expression of Mesp1 from day 2 to day 3,
1 day earlier than its endogenous expression, and monitored the
temporal appearance of beating EBs. In the absence of Dox, no
expression of transgene was detectable by FACS, western blot,
or immunostaining analysis (Figures S1B–S1D). Upon Dox addi-
tion, Mesp1 is rapidly induced, and 12 hr after Dox administra-
tion, Mesp1 is clearly seen in the nucleus of ESCs. After 24 hr,
about 80% of ESCs expressed Mesp1 (Figures S1B–S1D). The
precocious expression of Mesp1 resulted in an acceleration of
cardiac differentiation as demonstrated by the premature ap-
pearance of beating cells in the EB culture, which occurred at
day 7, a day earlier than in untreated cells or control GFP-induc-
ible ESCs treated with Dox (Figure 1B). A close observation of the
EBs revealed an increased number of beating zones within EBs
that have been stimulated with Mesp1 (Movies S1 and S2).
Immunofluorescence and FACS analysis demonstrated the
precocious and increased expression of TroponinT, a cardiac
specific marker, following Mesp1 induction (Figures 1C–1F).
Mesp1-stimulated cells generated four to five times more car-
diac cells (Figures 1E and 1F), which represents one, if not the
greatest, promotion of cardiac differentiation induced by a single
factor.
Mesp1 Specifically Promotes the Specification
of Multipotent Cardiovascular Progenitors
from Primitive Mesoderm
During embryonic development or ESC differentiation, cardiac
cells are thought to arise from the differentiation of MCPs (Murry
and Keller, 2008). To determine whether Mesp1 promotes the
specification of MCPs or whether its effect is restricted to theFigure 1. Precocious Expression of Mesp1 Dramatically Accelerates and Increases Cardiac Differentiation from ESCs
(A) Expression profiles of early mesodermal (Brachyury and Mesp1) and cardiac transcripts (Nkx2-5, Gata4, Mef2c, Hand2, and TroponinT2) during normal ESC
differentiation as measured by RT-PCR. Data represent relative expression of transcripts compared to undifferentiated ESCs as mean ± standard error of the
mean (SEM) of three biologically independent experiments.
(B) A pulse of Mesp1 (day 2 [D2] and day 3 [D3]), before its endogenous expression, accelerates cardiac commitment in EBs as detected by the precocious
appearance of beating areas, compared to unstimulated or GFP overexpressing cells, while a continuous administration of Dox inhibits cardiac differentiation.
Data represent mean ± SEM of three biologically independent experiments.
(C) EBs were stained with anti-troponinT antibody, a specific marker of cardiomyocytes. Mesp1 expression during D2 and D3 induced precocious troponinT
expression. Squares indicate areas of magnification for each condition shown on the right of the panel.
(D and E) Quantification of troponinT expression during ESC differentiation by FACS. At different times, EBs were dissociated, stained for troponinT and analyzed
by FACS. Data represent mean ± SEM of three biologically independent experiments.
(F) Absolute enrichment in troponinT positive cells following transient Mesp1 expression. The percentage of troponinT-positive cells was adjusted for the total
number of cells presented in both conditions (see Figure S4).Cell Stem Cell 3, 69–84, July 2008 ª2008 Elsevier Inc. 71
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and immunostaining, the expression of markers specific for dif-
ferent types of mature cardiovascular cells. Mesp1 increased
the expression of cardiac transcription factors (Figure 2A), pan-
cardiac markers (Figures 1C and 2A; Figure S2A), ventricular
markers (Figures 2A and 2B), atrial markers (Figures 2A and
2C), as well as markers of pace maker cells (Figure 2A). In addi-
tion to promoting myocardial differentiation, Mesp1 also acceler-
ated and promoted the differentiation of vascular cells as shown
by the precocious and increased expression of CD31 and VE-
Cadherin (Figures 2A and 2D) and smooth muscle cells as shown
by expression of smooth muscle actin (SMA) (Figure 2E). Alto-
gether, the three main cell lineages arising from the differentia-
tion of MCPs represent about 50%–60% of all cell lineages
following Mesp1 induction. The similar promotion and accelera-
tion of ESC differentiation into cardiac, vascular, and smooth
muscle cells suggested that Mesp1 induced the specification
of MCPs rather than just promoting cardiac differentiation.
Two distinct sources of cardiogenic mesoderm give rise to
MCPs during embryonic development and ESC differentiation
(Buckingham et al., 2005; Laugwitz et al., 2008). The primary
heart field originates from the anterior splanchnic mesoderm
and gives rise to the cardiac crescent, which contributes to the
development of left ventricle and atria. The secondary heart field
is derived from the pharyngeal mesoderm, anterior to the cardiac
crescent, and is marked by the expression of Islet1 (Isl1), a tran-
scription factor of the LIM-homeo-domain family. During ESC
differentiation, Isl1 protein is first detected around D6 and rea-
ches its maximum at D8, and its expression can be used to iso-
late multipotent cardiovascular progenitors of the secondary
heart field (Moretti et al., 2006). To determine whether Mesp1
promotes the specification of MCPs from the primary and/
or the secondary heart field, we monitored the expression of
Isl1 following Mesp1 induction. In Mesp1 stimulated cells,
Isl1 mRNA expression was increased 4 days after Dox addition
(D6). This effect was only transient, and Isl1 expression returned
to the control level at D8 (Figure 2F). Immunostaining of EBs re-
vealed the precocious expression of Isl1 in Mesp1-stimulated
cells in which EBs at D6 contained as many Isl1-positive cells
as control cells 2 days later (Figure 2G). Immunostaining re-
vealed the presence of cells that coexpressed Isl1, Flk1, and
Nkx2-5 following Mesp1 induction, consistent with the specifica-
tion of MCPs from the secondary heart field by Mesp1
(Figure S2B) (Moretti et al., 2006).
To determine whether Mesp1 promotes the fate of other cell
types during ESC differentiation, we analyzed the expression
of a panel of markers specific for a wide range of differentiatedcells that are produced after 10 days of ESC differentiation
(Keller, 2005). Besides promoting an increase in the expression
of cardiovascular markers, Mesp1 also increased the expression
of hepatic markers such as albumin, alpha-feto protein, and
TCF1 (Figure 2H), consistent with known cell nonautonomous-
promoting effect of cardiac cells during liver development (Zaret,
2000). Mesp1 also promoted the expression of striated muscle
cell markers such as MyoD or Myogenin (Figure 2H), but this ef-
fect only appeared around day 10 (Figure 2H and data not
shown) during the late stage of ESC differentiation potentially re-
lated to the later expression and function of Mesp1 in the preso-
mitic and somitic mesoderm (Saga, 1998; Takahashi et al.,
2005). Expression of markers for other mesodermal derivatives,
such as hematopoieitic tissue (Gata1, Tie2), bone (runx2,
Col1a1), endodermal, or ectodermal derivatives were un-
changed or relatively decreased in Mesp1 stimulated cells
(Figure 2H).
Mesp1 Specifies Multipotent Cardiovascular Progenitor
Cell Fate by an Intrinsic and Cell Autonomous
Mechanism
To identify the cellular mechanisms by which Mesp1 promotes
MCP specification, we first determined whether the addition of
conditioned media (CM) from Mesp1-stimulated cells to control
cells could recapitulate the cardiac-promoting effect of Mesp1
expression (Figure S3A). The daily addition of CM from Mesp1-
stimulated cells did not promote or accelerate cardiac differenti-
ation in control cells (Figure S3B), indicating that Mesp1 does not
promote cardiovascular specification by the secretion of soluble
proteins. To validate these observations, we cocultured Mesp1-
IRES-GFP EBs with EBs that expressed the red fluorescent
protein DsRed (Figure S3C). While 80% EBs that expressed
Mesp1 (GFP positive) showed beating zones at day 7, only 20%
of neighboring EBs that expressed DsRed presented signs of car-
diac contraction at this stage (Figure S3D). We quantified this ef-
fect by determining the expression of troponinT in cells express-
ing Mesp1 (GFP positive) and in control cells (DsRed) by FACS
analysis (Figure S3E). At day 8, 18% of Mesp1 stimulated cells
expressed troponinT, whereas only 4% of the DsRed cells of
the neighboring coculture EBs expressed this marker, similar to
control cells.
As a more rigorous test of an autonomous or nonautonomous
mechanism, we generated chimeric EBs in which ESCs condi-
tionally expressing Mesp1 and DsRed are mixed together to
form EBs containing both cell types (Figure 3A). These chimeric
EBs were stimulated with Dox, and cardiac differentiation (tropo-
ninT +) was measured in the Mesp1 (GFP+) or control (DsRed+)Figure 2. Mesp1 Specifically Promotes Multipotent Cardiovascular Progenitor Cell Fate
(A) Expression of cardiovascular markers analyzed by RT-PCR after 10 days of differentiation in Mesp1 stimulated cells (black bars) versus unstimulated cells at
the same time (white bars). These data show an enhancement cardiovascular markers following Mesp1 induction. Data represent mean ± SEM of four biologically
independent experiments.
(B–E) (B) Immunostainings of EBs for myosin light chain 2v (mlc2v), (C) myosin light chain 2a (mlc2a), (D) VE-cadherin, and (E) smooth muscle actin (SMA). These
immunostainings demonstrate acceleration and enhancement in atrial, ventricular, and vascular markers expression in Mesp1-stimulated EBs. Squares indicate
areas of magnification for each condition represented on the right of the panel.
(F) Expression of Islet1 as measured by RT-PCR following Mesp1 induction. Each result is normalized for the expression of unstimulated cells at the same time of
differentiation. Data represent mean ± SEM of three biologically independent experiments.
(G) Immunostaining of Islet1 in EBs demonstrates a precocious expression of islet1 at day 6 in Mesp1-induced EBs.
(H) Expression of other mesodermal, endodermal, and neurectodermal markers analyzed by RT-PCR after 10 days of differentiation in Mesp1-stimulated cells
(black bars) versus unstimulated cells at the same time (white bars). Data represent mean ± SEM of four biologically independent experiments.Cell Stem Cell 3, 69–84, July 2008 ª2008 Elsevier Inc. 73
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was much higher in Mesp1-stimulated cells (15%) than in DsRed
cells that had been in direct contact with Mesp1 stimulated cells
(6%) or in DsRed cells than have been in direct contact with GFP
cells (4%) (Figure 3B). These results showed that Mesp1 pro-
Figure 3. Mesp1 Promotes Cardiac Progenitor Cell Fate by an
Intrinsic and Cell Autonomous Mechanism
(A) Schematic representation of chimeric EB experiment. Equivalent cell num-
ber of Mesp1-IRES-GFP cells or control GFP ES cells were mixed with DsRed
expressing cells.
(B) TroponinT expression in Mesp1-expressing cells (GFP positive) or in con-
trol cells (DsRed positive) was measured by FACS analysis after 8 days of dif-
ferentiation. Percentage of troponinT-positive cells is much higher in Mesp1-
stimulated cells than in DsRed stimulated cells or in DsRed cells that have
been in contact with GFP cells, demonstrating that Mesp1 promotes cardiac
specification mainly through a cell autonomous mechanism. Data represent
mean ± SEM of three biologically independent experiments.74 Cell Stem Cell 3, 69–84, July 2008 ª2008 Elsevier Inc.motes cardiac specification through an intrinsic and cell autono-
mous mechanism.
Effect of Mesp1 on Cardiac Progenitor Cell Expansion
After 48 hr of Mesp1 induction, EBs were bigger and presented
two times more cells than control EBs (Figures S4A and S4B).
However, the growth advantage of Mesp1-stimulated cells was
only transient as 3 days after Mesp1 induction, both Mesp1-
stimulated and control cells grew at the same rate
(Figure S4B). FACS analysis 48 hr after Mesp1 induction re-
vealed that Mesp1 induction did not significantly modify the
cell-cycle profile of these cells (Figure S4C), but apoptosis was
significantly reduced in Mesp1-stimulated cells (Figure S4D),
suggesting that the transient growth advantage observed follow-
ing Mesp1 induction is related to a transient inhibition of apopto-
sis. The small and transient cell growth advantage observed in
Mesp1-stimulated cells contrasted with the major increase in
cardiovascular differentiation induced by Mesp1, suggesting
that Mesp1 promotes cardiovascular cell-fate specification
through an instructive rather than selective mechanism.
Mesp1 Directly Regulates the Expression of the Core
Cardiac Transcriptional Machinery
To uncover the molecular mechanisms by which Mesp1 induced
cardiovascular specification, we performed a genome-wide
analysis of Mesp1-regulated genes. We determined which genes
were regulated upon Mesp1 induction by at least 1.5-fold in two
separate experiments. Mesp1 regulated a discrete set of genes
(586 of 45101 probes), corresponding to 1.3% of the murine ge-
nome. Among the 423 unique annotated genes that were rapidly
modulated upon Mesp1 induction, 276 were upregulated,
whereas 148 were downregulated, suggesting that Mesp1 ex-
erts its function by both positive and negative regulation of
gene expression.
Cardiac morphogenesis and differentiation are governed by
an evolutionarily conserved set of transcriptional factors that
regulate the expression of genes implicated in morphogenesis
and patterning during heart development as well as the genes re-
quired for cardiac terminal differentiation (Olson, 2006). Our mi-
croarray analysis revealed that Mesp1 induced the rapid upregu-
lation of many, if not all, genes belonging to the core cardiac
transcriptional machinery:Hand2,Gata4,Gata6, Tbx 20, orMyo-
cardin (Table 1). In addition to these genes, we found that
Nkx2-5 and Mef2c, although not listed in our microarray analysis
due to their low levels of expression, were also upregulated by
RT-PCR (Figure 4A). Other genes playing important role during
cardiovascular development, such as Hey2 or Foxc1 (Fischer
et al., 2004; Kume et al., 2001), were also rapidly upregulated fol-
lowing Mesp1 induction (Table 1).
To study in more detail how Mesp1 regulates the expression of
these key cardiac transcriptions factors, we investigated, by RT-
PCR, the kinetics of their upregulation following Mesp1 expres-
sion. As early as 18 hr following Dox addition, only 6 hr after
the appearance of Mesp1 in the nucleus of ESCs, expression
of Hand2, Myocardin, Gata4, FoxH1, and FoxC1 were upregu-
lated by 2- to 15-fold (Figure 4A). For most of these genes, the
maximum increase in gene expression occurred 24 hr following
Mesp1 induction, although a sustained increase in the expres-
sion of Hand2, Myocardin, Nkx2-5, Mef2c, or FoxC1 was still
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Upregulated Genes Downregulated Genes
Transcription
factors
Ripply2 (43.7), Cited1 (36.8),* Trim9 (22.7), Foxl2os (17.9),
Hey2 (13.8),* Otx1 (13.6), dHand (6.7),* Ebf2 (6.3), Lhfp (5.5),
Snai1 (4.9),* Lef1 (4.3),* Nfatc1 (4.0),* Pdlim4 (4.0), Myocd
(3.7),* Pdlim2 (3.5), Asxl3 (3.3), Foxc1 (3.2),* sVax1 (3.1), Twist1
(3.1),* Fli1 (2.9), Fosl2 (2.8), Klhl6 (2.8), Zeb1 (2.7), Ankrd6
(2.6),* Insm1 (2.6), Gata4 (2.4),* Hes6 (2.6), Spic (2.5), Hmga2
(2.5),* Gbx2 (2.3), Pdlim5 (2.3), Dmrta1 (2.3), Ankrd1 (2.3),*
sFOG (2.3),* Hmgn3 (2.2), Dact1 (2.1), Zfp711 (2.1), Pbx1 (2.1),
Zfp238 (2.1), Specc1 (2.1), Hdgfrp3 (2.1), Dachshund1 (2.1),
Etv2 (2.0),* Tshz1 (2.0), Hoxd13 (2.0), Tox (1.9), Lmo1 (1.9),
Tbx20 (1.9),* Creb3l2 (1.9), Tbx3 (1.9),* Lbx1 (1.9), Gata6 (1.8),*
Phc2 (1.8), L3mbtl3 (1.8), Neurod1 (1.7), Foxh1 (1.7),* Dicer
(1.7),* Tceal1 (1.7), Fhl1 (1.7),* Sap30l (1.6), Ppfibp1 (1.6), Zeb2
(1.6),* Cbx2 (1.6), Sox4 (1.6),* Smad1 (1.6),* and Pitx2 (1.6)*
T (8.5), Foxa2 (6.3), Sox17 (6.2), Ldb2 (4.6), Klhl4 (4.3), Gsc
(3.3), Sp8 (3.1), Id2 (2.7), Eras (2.7), Mixl1 (2.4), Zic5 (2.4), Irf6
(1.9), Foxd3 (2.1), Bhlhb2 (2.1), Nr5a2 (1,9), Hopx (1.9), Tox3
(1.8), Nkx6.3 (1.8), Prdm1 (1.8), Tcfcp2l1 (1.8), Dmrt1 (1.8),
Esrrb (1.7), Mycl1 (1.7), Mcf2l (1.7), Nr0b1 (1.7), Pycard (1.7),
Ltbp4 (1.6), Mybl2 (1.6), Klf2 (1.6), and Pcaf (1.5)
Signaling Notch: ligands: Dll3 (12.3), Dll1 (3.2), Dlk1 (3.0); receptors:
Notch1 (2.5), Notch4 (2.0), Notch3 (1.6); downstream
transcription factors: Hey2 (13.8), Hes6 (2.6)
Wnt: Wnt5a (6.5), Lef1 (4.3) Frzb (3.1)
FGF: Fgf3 (3.5) Fgf8 (5.5), Fgf5 (2.6), Fgf17 (1.9)
TGF-b: Tgfb1i1 (3.4), Fstl1 (2.9) Fst (5.1), Cer1 (3.9), Nodal (1.5)
Ras: Rhob (2.6), Rasl11b (2.3), Rasgrp3 (21.3), Rragd (1.7) Rab25 (2.2), Shb (2.8)
Fold change is indicated in parentheses. Asterisks indicate transcription factors that are expressed and/or implicated during cardiovascular differen-
tiation.observed after 48 hr or 72 hr of Mesp1 stimulation (Figure 4A).
Addition of low dose of Dox, which induced Mesp1 at a lower
level than the peak of its endogenous expression (Figure S1E),
also stimulates the expression of these transcription factors
(Figure S5A), demonstrating that promotion of these genes
was not due to supraphysiological level of Mesp1. The very rapid
upregulation of these genes by Mesp1 strongly suggested that
they represent direct Mesp1 target genes. Other genes, such
as Isl1 (Figure 2F), did not present their maximal expression until
96 hr following Mesp1 induction, suggesting an indirect mode of
regulation of these genes by Mesp1.
To determine whether these cardiac transcription factors are
direct Mesp1 target genes, we performed chromatin immuno-
precipitation (ChIP) analysis following Mesp1 induction and de-
termined, by PCR analysis, whether ChIP using anti-Mesp1 an-
tibody (Ab) enriched for DNA fragments containing conserved
putative Mesp1 binding sites (EBox). Quantitative PCR analyses
were performed for DNA fragments showing different amounts of
PCR products following ChiP using anti-Mesp1 and isotype con-
trol antibodies (Figures S5–S8). Hand2 gene contains many con-
served EBox sites in several conserved regions of its promoter
(Figure 4B). Our ChIP experiments demonstrated that multiple
regions within the Hand2 promoter were enriched using Mesp1
Ab (Figure 4C and Figure S5B). The strongest enrichment (about
20-fold) was found within a genomic region located 2.8 kB up-
stream of the ATG, a genomic region corresponding to the pre-
viously identified cardiac enhancer of Hand2 (McFadden et al.,
2000). We identified other DNA regions also enriched following
Mesp1 ChIP (Figures 4B and 4C; Figure S5B), whereas several
other regions containing a cluster of conserved EBox sites within
Hand2 promoter were not significantly enriched by Mesp1 ChIP
(Figure 4C and Figure S5B), suggesting that Mesp1 bindsdirectly and specifically to different promoter regions of Hand2,
encompassing the previously identified cardiac enhancer
(McFadden et al., 2000). To validate these results using another
assay, we tested the ability of different Hand2 enhancers to pro-
mote transactivation of a reporter construct by Mesp1. Mesp1
stimulated the expression of reporter constructs containing the
two distal enhancers and the more proximal cardiac enhancer,
while no stimulation was observed in reporters without enhancer
or containing a Hand2 enhancer without conserved EBox (Fig-
ure S5F). We identified one DNA region within the proximal pro-
moter of myocardin containing a conserved EBox site that was
strongly enriched by ChIP using Mesp1 Ab (about 20-fold) (Fig-
ures 4D and 4E; Figure S5C). The Nkx2-5 promoter contained
at least three regions enriched for Mesp1 binding (Figures 4F
and 4G; Figure S5D). Two of them are located in genomic regions
previously identified as enhancers that promote Nkx2-5 expres-
sion in the cardiac crescent and heart tube (Schwartz and Olson,
1999).Gata4 contained two genomic regions located in the prox-
imal promoter strongly enriched following Mesp1 ChIP, whereas
other regions containing conserved EBox sites and located more
upstream were not enriched by Mesp1 Ab (Figures 4H and 4I;
Figure S5E).
Mesp-1 Represses the Expression of Genes Regulating
Pluripotency, Early Mesoderm, and Endoderm Cell
Fates
Our microarray analyses indicated that Mesp1 rapidly repressed
the expression of several genes implicated in the maintenance of
pluripotency such as Id2 and Eras (Table 1) (Takahashi et al.,
2003; Ying et al., 2003). We expanded our analysis by examining
the expression of other key regulators of pluripotency by RT-
PCR (Jaenisch and Young, 2008). Expression of Nanog, Oct4,Cell Stem Cell 3, 69–84, July 2008 ª2008 Elsevier Inc. 75
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less rapidly than Eras or Id2, suggesting they do not represent di-
rect Mesp1 target genes (Figures 5A and 5B). Using immunos-
taining, we found that Nanog disappeared more rapidly during
ESC differentiation in Mesp1-stimulated cells compared to con-
trol cells (Figure 5C).
During early gastrulation, specification of the primitive streak
to mesoderm and endoderm cell fate is tightly regulated tempo-
rally and spatially by specific transcription factors such as
Brachyury, Sox17, Foxa2, and also by different extrinsic factors
such as Wnts or Nodal (Tam et al., 2003; Tam and Loebel, 2007).
The formation of cells of the primitive streak also occurs during
ESC differentiation and gives rise to either mesoderm or endo-
derm cells (Murry and Keller, 2008). Our microarray analysis
showed that Brachyury (T) and FGF8, which are expressed
throughout the primitive streak, as well as Foxa2 and Sox17,
which are expressed in the anterior primitive streak and control
the specification of definitive endoderm lineages, were among
the five most downregulated genes following Mesp1 induction
(Table 1). Several other genes important for early mesoderm
and endoderm specification, such as Nodal, Goosecoid,
Cerberus, Follistatin, and FoxD3 (Tam and Loebel, 2007), were
also downregulated following Mesp1 induction, suggesting that
Mesp1 selectively represses genes implicated in the specifica-
tion of other early mesoderm and endoderm cell fates (Table 1).
We used RT-PCR to investigate in more detail the kinetics of
their transcriptional repression by Mesp1. Brachyury, Sox17,
FGF8, Foxa2, Gsc, and Cer1 were rapidly downregulated follow-
ing Mesp1 expression as soon as 12 hr after Dox addition and
reached their maximal downregulation 24 hr after Dox addition
(Figure 5D). Among these genes, Foxa2was the most downregu-
lated. Using immunostaining, we demonstrated that Foxa2 ex-
pression was indeed strongly downregulated in cells expressing
Mesp1 (Figure 5E).
To determine whether Mesp1 directly controls the expression
of these genes, we performed ChIP experiments following
Mesp1 induction and determined, using PCR analysis, whether
immunoprecipitated fragments contained conserved EBoxe
sites. Our ChIP experiments revealed that Mesp1 IP enriched
by about 20-fold DNA fragments containing one conserved
EBox site located 5 kB upstream of the ATG of Foxa2 (Figures
5F and 5G; Figure S6A). Our ChIP experiments showed that
DNA fragments located 4.5 kB upstream of the ATG of Gsc
and containing a cluster of 10 conserved EBox sites were en-
riched by 20-fold using anti-Mesp1 antibody (Figures 5H and
5I; Figure S6B). Our ChIP experiments revealed that Mesp1 IP
enriched by about 10-fold DNA fragments located 4 kB upstream
of the ATG of Sox17 (Figures 5J and 5K; Figure S6C). Mesp1
ChiP enriched by 5-fold DNA fragments located 1.5 kB upstreamof the ATG of Brachyury (Figures 5L and 5M; Figure S6D). The
specific binding of Mesp1 to regions of genomic DNA located
in Sox17, Gsc, Foxa2, and Brachyury revealed by our ChIP ex-
periments, together with their very rapid downregulation follow-
ing Mesp1 induction, strongly suggest that Mesp1 directly con-
trols the repression of genes involved in the specification of the
other cell types that arise during the early stages of gastrulation.
Mesp1 Directly Regulates Multiple Components of the
Canonical Notch andWnt Signaling Pathways and Prime
These Pathways toward Cardiac Commitment
Wnt and Notch signaling pathways are well known to regulate
different aspects of cardiovascular differentiation from progeni-
tor specification to cardiac and vascular cell terminal differentia-
tion (Cohen et al., 2008; Gridley, 2007).
Our microarray analysis revealed that many components of
the Wnt and Notch pathways were rapidly upregulated following
Mesp1 expression (Table 1). All three delta ligands, three of the
four Notch receptors, and two well-known downstream target
genes of the Notch pathway (Hey2, Hes6) were upregulated fol-
lowing Mesp1 induction (Table 1). The promotion of Notch li-
gands and Notch target gene expression mediated by Mesp1
was relatively transient, peaked after 24 hr, and decreased to
the basal level thereafter, whereas the increase in Notch1 ex-
pression was more sustained (Figure 6A). To investigate whether
Notch signaling was necessary for the cardiovascular specifica-
tion induced by Mesp1, we treated ESCs with N-[N-(3,5-Difluor-
ophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT),
a gamma-secretase inhibitor that prevents Notch activation
(Geling et al., 2002) while at the same time inducing Mesp1 ex-
pression. DAPT did not profoundly reduce the number of beating
EBs after 8 days of differentiation in control or Mesp1-stimulated
cells (Figure 6B). However, immunostaining analysis showed
that DAPT treatment from day 2 to day 4 caused a decrease in
the total number of troponinT- and VE-Cadherin-positive cells
in both control and Mesp1-stimulated cells (Figures 6C and
6D), suggesting that Notch influences MCPs specification and/
or early cardiovascular lineage commitment.
It has been recently suggested that Mesp1 promotes cardiac
differentiation through the upregulation of Dkk1, a soluble Wnt
inhibitor (David et al., 2008). Our microarray and RT-PCR analy-
sis revealed that Mesp1 promoted the expression of Lef1, a tran-
scription factor that relays canonical Wnt signaling, and Wnt5a,
a ligand of the noncanonical Wnt pathway, and decreased the
expression of Wnt3a, a ligand of the canonical Wnt pathway (Ta-
ble 1 and Figure 6E). We did not detect any change in Dkk1 ex-
pression following Mesp1 induction, neither by microarray nor
by real time RT-PCR (Figure 6F). We could not detect any enrich-
ment of Mesp1 bound to Dkk1 promoter by ChIP in the DNAFigure 4. Mesp1 Directly Promotes the Expression of the Core Cardiac Transcriptional Machinery
(A) Temporal expression of cardiovascular transcription factors following a transient Mesp1 induction. Results are normalized for the expression in Mesp1-un-
stimulated cells at the same time of differentiation and represent the mean ± SEM of three biologically independent experiments. These results demonstrate
a rapid upregulation of these genes, already detectable as early as 12–18 hr post-Dox stimulation. (B, D, F, and H) Representation of genomic regions surrounding
Hand2 (B),Myocardin (D),Nkx2-5 (F), andGata4 (H) genes. Untranslated regions are depicted in yellow. Exons are shown by wide blue lines and intron by thin blue
lines. The previously described cardiac enhancers are highlighted in green (McFadden et al., 2000; Schwartz and Olson, 1999). Conserved EBox sites between
human and mouse sequences and relative position of PCR fragments used to measure the enrichment following ChIP are represented by orange boxes. (C, E, G,
and I) Quantification of DNA fragment enrichment by ChIP using anti-Mesp1 antibody relative to control isotype antibody as measured by RT-PCR for Hand2 (C),
Myocardin (E), Nkx2-5 (G), and Gata4 (I). Data represent mean ± SEM of four biologically independent experiments.Cell Stem Cell 3, 69–84, July 2008 ª2008 Elsevier Inc. 77
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previously reported (Kwon et al., 2007; Lindsley et al., 2006;
Naito et al., 2006; Ueno et al., 2007), that Dkk1 addition during
ESC differentiation profoundly inhibits cardiac differentiation as
measured by the number of beating EBs (Figure 6G) and the
number of troponinT-positive cells (Figures 6H and 6I). Addition
of Dkk1 during Mesp1 induction also decreased significantly, but
not completely, the cardiac promoting effect of Mesp1 (Figures
6G–6I). We confirmed the promoting effect of Wnt3a addition
on Mesp1 expression (Figure S7C) (Ueno et al., 2007) and dem-
onstrated that addition of Dkk1 from D2 to D4 profoundly
inhibited Mesp1 expression (Figure 6J), suggesting that Wnt sig-
naling can act upstream of Mesp1 expression and potentially ex-
plains why Wnt signaling is important during cardiovascular
specification. Our results reinforce the prevailing notion that
stimulation of canonical Wnt signaling is required for cardiac pro-
genitor specification and/or expansion (Klaus et al., 2007; Kwon
et al., 2007; Lindsley et al., 2006; Naito et al., 2006; Qyang et al.,
2007; Ueno et al., 2007) but clearly demonstrated thatDkk1 is not
a direct Mesp1 target gene and that Dkk1 is not responsible for
the cardiac promotion mediated by Mesp1. Interestingly, while
Dkk1 addition in the early stage of ESC differentiation inhibits
cardiac specification, Dkk1 addition during the latter stage pro-
motes cardiac differentiation, suggesting that Wnt signaling
presents a biphasic effect during cardiac differentiation (Naito
et al., 2006; Ueno et al., 2007; Yang et al., 2008).
Mesp-1 Regulates Its Own Expression through
a Complex Gene Regulatory Circuit
Mesp1 and Mesp2 are well known to repress each other’s ex-
pression and possibly also their own expression (Kitajima
et al., 2000). Positive and negative autoregulatory loops are com-
mon mechanisms during cell-fate specification, ensuring a sharp
boundary of gene expression as well as transient gene expres-
sion (Alon, 2007). Our microarray analysis revealed that Ripply2,
a well known direct negative regulator of Mesp2 expression (Ka-
wamura et al., 2008; Morimoto et al., 2007), was the most upre-
gulated gene (about 50-fold) following Mesp1 induction (Table 1).
Ripply2 expression is barely detectable at day 3 of ESC differen-
tiation, and its expression was very rapidly and strongly upregu-
lated following Mesp1 induction (Figure 7A). We investigated, us-
ing ChIP experiments, whether Mesp1 directly binds to Ripply2
promoter. Our ChIP experiments revealed that Mesp1 Ab en-
riches, by 20-fold, DNA fragments located 6.5 kB upstream of
the ATG of Ripply2 and containing a cluster of four conserved
Ebox sites (Figures 7B and 7C; Figure S8A).
To determine whether Mesp1 regulates its own expression, we
measured the endogenous level of Mesp1 following Mesp1 in-
duction by designing RT-PCR primers specific for the 30UTR re-gion of endogenousMesp1mRNA that do not amplify theMesp1
mRNA of the inducible construct. Interestingly, Mesp1 expres-
sion initially stimulated its own expression, but this effect was
only transient. After 24 hr following Dox addition, the endoge-
nous expression of Mesp1 and Mesp2 were downregulated in
Mesp1-stimulated cells (Figure 7D). The rapid and transient stim-
ulation of Mesp1 expression following exogenous Mesp1 induc-
tion strongly suggested that Mesp1 first stimulated its own ex-
pression through a direct positive-feedback loop. We used
ChIP experiments to determine whether Mesp1 binds directly
to its own regulatory region. Our ChIP experiments revealed
that Mesp1 Ab enriched for DNA fragments located 4.6 kB up-
stream of the transcription initiation site of Mesp1 (Figures 7E
and 7F; Figure S8B), suggesting a direct autoregulation of
Mesp1. The subsequent downregulation of Mesp1 expression
suggested an indirect mechanism, possibly mediated by the in-
crease of Ripply2 expression.
DISCUSSION
Mesp1 Acts Intrinsically to Promote Multipotent
Cardiovascular Progenitor Specification from
Undifferentiated Mesoderm
ESC differentiation constitutes both a powerful method to dissect
the cellular and molecular mechanisms underlying cardiac-fate
decision and a potential source of cells for future cardiac and
vascular cellular therapy in humans (Keller, 2005; Martin-Puig
et al., 2008). In this study, we demonstrated that Mesp1 acts in
a cell-autonomous manner to promote the specification of
MCPs from the primary and secondary heart fields. This was
clearly demonstrated by the massive increase in cardiac, endo-
thelial, and smooth muscle cells and the upregulation of markers
common in both sources of cells (Nkx2-5, Gata4, Hand2, Tbx20,
FoxH1) and specific for the primary (e.g., Tbx5) and the second-
ary (e.g., Isl1) heart field following Mesp1 induction.
Recently, it was proposed that Mesp1 induces cardiac spec-
ification through the secretion of Dkk1, a soluble Wnt inhibitor,
suggesting that cardiac-fate specification induced by Mesp1 oc-
curred through a cell-nonautonomous mechanism (David et al.,
2008). However, the data presented here using conditioned me-
dium from Mesp1 stimulated cells, coculture of Mesp1, and con-
trol EBs, as well as the codifferentiation of chimeric EBs, demon-
strates unambiguously that cardiovascular specification induced
by Mesp1 is mediated predominantly through an intrinsic and
cell-autonomous mechanism. However, the small promotion of
cardiac differentiation (about 15% of the total promotion of car-
diac differentiation induced by Mesp1) observed in the non-
Mesp1-expressing cells leaves open the possibility of a minor
contribution of a non-cell-autonomous effect of Mesp1 duringFigure 5. Mesp1 Represses the Expression of Genes Regulating Pluripotency, Early Mesoderm, and Endoderm Cell Fates
(A and B). Expression of Eras and Id2 (A), Oct4, Nanog, and Sox2 (B) mRNAs following a transient Mesp1 expression determined by RT-PCR. Results are nor-
malized for expression in unstimulated cells at the same time of differentiation. Note the more rapid downregulation of Eras and Id2 expression (A) compared to
Oct4, Nanog, and Sox2 expression (B). Data represent mean ± SEM of three biologically independent experiments. (C) Immunostaining for Nanog on cytospins
48 hr after Dox stimulation (D4). (D) Temporal expression of early mesodermal and endodermal markers following Mesp1 induction using RT-PCR analysis.
Results are normalized for the expression in Mesp1 unstimulated cells at the same time of differentiation. Data represent mean ± SEM of three biologically in-
dependent experiments. (E) Immunostaining for Foxa2 at D6 showed the downregulation in Foxa2 expression following Mesp1 induction. (F, H, J, and L) Rep-
resentation of genomic regions surrounding Foxa2 (F), Gsc (H), Sox17 (J), and Brachyury (L) genes has been performed as described in Figure 4. (G, I, K, and M)
Quantification of DNA fragments enrichment by ChIP using anti-Mesp antibody relative to control isotype antibody as measured by RT-PCR for Foxa2 (G),Gsc (I),
Sox17 (K), and Brachyury (M). Data represent mean ± SEM of four biologically independent experiments.Cell Stem Cell 3, 69–84, July 2008 ª2008 Elsevier Inc. 79
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Mesp1 Functions in Cardiovascular SpecificationFigure 6. Mesp1 Directly Regulates Multiple Components of the Canonical Notch and Wnt Signaling
(A) Temporal expression of Dll1,Dll3,Dll4, Notch1, Notch4,Hes6, and Hey2 following Mesp1 expression as determined by RT-PCR analysis. Results are normal-
ized for the expression in Mesp1 unstimulated cells at the same time of differentiation. Data represent mean ± SEM of three biologically independent experiments.
(B) Percentage of beating EBs at day 8 (D8) following the administration of DAPT, an inhibitor of Notch activation, during day 2 (D2) and day 3 (D3) of ESC
differentiation. Data represent mean ± SEM of three biologically independent experiments.80 Cell Stem Cell 3, 69–84, July 2008 ª2008 Elsevier Inc.
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vivo chimeric studies showing that Mesp1/2 null cells cannot
generate cardiac cells despite the presence of wild-type cells,
demonstrating the cell autonomous role of Mesp1/2 during
mouse cardiac development (Kitajima et al., 2000).
Mesp1 Directly Promotes the Expression of Key
Components of the Core Cardiac Transcriptional
Machinery
The core cardiac transcriptional machinery is composed of an
evolutionarily conserved set of transcription factors that rein-
force each other’s expression and can stimulate alone or in com-
bination the expression of genes required for proper cardiac de-
velopment (Davidson and Erwin, 2006; Olson, 2006). Little is
known about the upstream factors that initiate expression of
these key cardiac transcription factors during development, re-
sulting in their coregulated expression in the cardiac crescent
of the primary and secondary heart fields. Our study demon-
strates that Mesp1 rapidly and strongly stimulated the expres-
sion of Hand2, Myocardin, Nkx2-5, Gata4, Mef2c, Tbx20, or
FoxH1. Our ChIP experiments showed that Mesp1 directly binds
the previously described cardiac enhancers of Hand2 and Nkx2-
5 (McFadden et al., 2000; Schwartz and Olson, 1999) and in var-
ious regulatory regions of the proximal promoter of Myocardin
and Gata4. The strength of Mesp1 binding to the regulatory re-
gions of these genes correlates well with the importance and
the kinetics of their upregulation following Mesp1 expression,
strongly suggesting that Mesp1 directly regulates their transcrip-
tion. It has recently been shown that in ESCs in which Mesp1 has
been knockdown, Nkx2-5 and Gata4 are no longer upregulated
during differentiation, suggesting that Mesp1 is required for their
upregulation (David et al., 2008). Our results place Mesp1 at the
top of the transcriptional network that regulates cardiac differen-
tiation by directly coordinating the expression of the majority of
key cardiac transcription factors at the right place and at the right
time (Figure 7G). A similar function of Mesp1, in coordinating car-
diac specification by regulating cardiac gene expression, has
also been suggested to occur during heart development in Ciona
intestinalis, one of the most primitive chordates (Davidson et al.,
2005). Clearly, further studies are needed to more precisely de-
termine the Mesp1-binding sites to these regulatory regions and
to determine the in vivo and the evolutionary significance of our
findings during vertebrate cardiac specification.
Mesp1 Directly Represses the Transcription of Genes
Regulating Alternate Cell Fates
Developmental processes are dynamic in nature and always
progress. Mesp1 downregulated the expression of about a hun-
dred genes. The genes downregulated by Mesp1 included manygenes involved the specification of early mesoderm and endo-
derm cell fates (Figures 5D and 7G). Mesp1 directly downregu-
lated the expression of Brachyury and FGF8, which both act dur-
ing early primitive streak specification, as well as Foxa2, Sox17,
Gsc, Nodal, and Cer1, which all function during endoderm spec-
ification (Tam et al., 2003; Tam and Loebel, 2007). The temporal
analysis of this gene expression following Mesp1 induction dem-
onstrates that some genes (e.g., Brachyury, Foxa2, Gsc, and
Sox17) were already strongly repressed only a few hours after
the presence of Mesp1 in the nucleus (Figure 5D). These data, to-
gether with the direct demonstration that Mesp1 is bound to their
regulatory region, strongly suggest that Mesp1 directly controls
the transcription of these genes. The in vivo relevance of our find-
ings is illustrated by the expanded and increased expression of
Fgf8, Foxa2, Cereberus, Goosecoid, and Nodal in embryos defi-
cient for Mesp1/2, demonstrating that Mesp1/2 negatively con-
trolled expression of these key developmental genes in vivo as
well (Kitajima et al., 2000; Saga et al., 1999). The repression of
these early mesodermal and endodermal genes by Mesp1 may
ensure that Mesp1 specifically, unidirectionally, and irreversibly
induces the promotion of cardiovascular specification and
inhibits the acquisition of other possible cell fates during this
developmental stage.
Mesp1 Negatively Regulates Its Expression through
a Complex Gene Regulatory Network
We demonstrated that Mesp1 rapidly but transiently stimulated
its own endogenous expression, probably through a direct
mechanism as suggested by our ChIP experiments. This tran-
sient increase in Mesp1 expression is followed by a sustained
and profound downregulation of its own endogenous expres-
sion. The most upregulated gene following Mesp1 stimulation
is Ripply2, a transcriptional corepressor (Kawamura et al.,
2008). Ripply2 was recently shown to be a direct target gene
of Mesp2 as well as a negative regulator of Mesp2 expression
in vivo (Morimoto et al., 2007). Our ChIP experiments demon-
strated that Ripply2 is also a direct Mesp1 target gene, and our
temporal expression analysis following Mesp1 stimulation
showed that the profound and sustained upregulation of Ripply2
following Mesp1 stimulation is correlated with the secondary
repression of Mesp1 expression, suggesting that Ripply2
may mediate the secondary negative autoregulatory loop of
Mesp1 expression. Using Mesp1 lacZ knockin mice, Saga and
colleagues demonstrated that Mesp1 negatively regulates its
own expression in vivo (Saga et al., 1999). The positive and
then negative autoregulation of Mesp1 presumably ensures
that Mesp1 acts as a gene regulatory switch during cardio-
vascular specification during embryonic development and ESC
differentiation.(C and D) Immunostainings at day 8 for troponinT (C) and VE-cadherin (D) following DAPT administration during D2 and D3. DAPT treatment during D2-D3
decreases the number of troponinT- and VE-cadherin-positive cells.
(E and F) Temporal expression of Lef1, Wnt3a and Wnt5a (E), and Dkk1 (F) following Mesp1 expression. Results are normalized for expression in unstimulated
cells at the same time of differentiation. Data represent mean ± SEM of three biologically independent experiments.
(G) Percentage of beating EBs determined at D8 following addition of Dkk1 (D2-D3). Addition of Dkk1 resulted in an inhibition of cardiac differentiation in both
control and Mesp1-stimulated cells. Data represent mean ± SEM of three biologically independent experiments.
(H and I) Inhibition of cardiac differentiation (troponinT) following Dkk1 administration, determined by FACS analysis (H) and immunostaining for troponinT (I) at
day 10.
(J) Repression of Mesp1 expression following Dkk1 administration from D2 to D3 in unstimulated cells, as measured by RT-PCR at D3. Results are normalized for
Mesp1 expression in untreated cells at the same day. Data represent mean ± SEM of three biologically independent experiments.Cell Stem Cell 3, 69–84, July 2008 ª2008 Elsevier Inc. 81
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(A) Temporal expression of Ripply2 following Mesp1 expression as determined by RT-PCR analysis. Ripply2 expression is strongly and rapidly upregulated fol-
lowing Mesp1 induction. Results are normalized for Ripply2 expression in unstimulated cells at the same time of differentiation. Data represent mean ± SEM of
three biologically independent experiments.82 Cell Stem Cell 3, 69–84, July 2008 ª2008 Elsevier Inc.
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Our study provides important insights into the molecular mech-
anisms that promote the specification of MCPs from ESCs. We
demonstrate that Mesp1 acts as a key molecular switch during
this process, residing at the top of the hierarchy of the cardiovas-
cular transcriptional network and stimulating the coordinated
expression of the main transcription factors necessary for car-
diovascular development (Figure 7G). Our genome-wide tran-
scriptional analysis of Mesp1 target genes provides a compre-
hensive analysis of the earliest molecular mechanisms
controlling cardiovascular commitment, which will constitute
a framework for further exploration of the complex transcrip-
tional network involved in cardiovascular progenitor specifica-
tion. In addition, our study provides a robust method for gener-
ating cardiovascular cells during ESC differentiation and opens
new avenues for cardiac cellular therapy in humans.
EXPERIMENTAL PROCEDURES
Tetracycline-Inducible Mesp1 ESC Line
Murine Mesp1 ORF was cloned with a C terminus 33 flag sequence and an
IRES-GFP. This constructed was electroporated in A2Lox cells (M.I. and
M.K., unpublished data). Further details are documented in the Supplemental
Data.
ESCs Culture and Differentiation
A2Lox ESCs were maintained on irradiated MEFs. Medium composition and
hanging drop differentiation protocol are described in the Supplemental
Data. When indicated, RmDKK1 (R&D) was used at a final concentration of
600 ng/ml and DAPT at a final concentration of 2.5 mM.
RNA Isolation and Microarray Analysis
Uninduced and induced Mesp1 cells were collected 24 hr postdoxycyclin
stimulation. RNAs were purified using Absolutely RNA kit (Stratagene), labeled,
and hybridized on a mouse genome 430 2.0 array. Raw microarray images
were quantified using Gene ChIP Operating Software (GCOS, Affymetrix).
Analysis parameters are described in the Supplemental Statistical Analysis.
Reverse Transcription and Quantitative PCR
Reverse transcription and quantitative PCR procedures are described in the
Supplemental Experimental Procedures.
Immunofluorescence Analysis
Staining procedures and antibodies used are described in the Supplemental
Experimental Procedures.
Chromatin Immunoprecipitation Assay
ChIP assays were performed in embryoid bodies at 36 hr after Dox induction.
For all ChIP experiments, the anti-Flag M5 or the related isotype was used for
the immunoprecipitation step as described in the Supplemental Data. Quanti-
tative PCR analyses were performed for DNA fragments showing different
amount of PCR products following ChiP using anti-Mesp1 and isotype control
antibodies. Relative occupancy values were calculated by the ratios of amountof antibody-immunoprecipitated DNA over that of the isotype sample. Detailed
procedures and a list of primers used for ChIP-PCR are documented in the
Supplemental Data.
Statistical Analysis
Statistical analysis is described in detail in the Supplemental Data.
SUPPLEMENTAL DATA
The Supplemental Data include eight figures, Supplemental Statistical Analy-
sis, Supplemental Experimental Procedures, two tables, and two movies and
can be found with this article online at http://www.cellstemcell.com/cgi/
content/full/3/1/69/DC1/.
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